KMPH - KemPharm, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2019
12/30/2018
12/30/2017
12/30/2016
Total Revenue
12,839
12,839
0
0
0
Cost of Revenue
2,945
2,945
-
-
-
Gross Profit
9,894
9,894
-
-
-
Operating Expenses
Research Development
19,415
19,415
41,759
20,593
20,472
Selling General and Administrative
10,816
10,816
12,508
12,773
17,010
Total Operating Expenses
30,231
30,231
54,267
33,366
37,482
Operating Income or Loss
-20,337
-20,337
-54,267
-33,366
-37,482
Interest Expense
6,514
6,514
7,087
7,337
7,127
Total Other Income/Expenses Net
1,998
1,998
4,342
-3,091
27,725
Income Before Tax
-24,544
-24,544
-56,592
-43,429
-16,531
Income Tax Expense
-22
-22
-126
-43
-15
Income from Continuing Operations
-24,522
-24,522
-56,466
-43,386
-16,516
Net Income
-24,522
-24,522
-56,466
-43,386
-16,516
Net Income available to common shareholders
-24,522
-24,522
-56,466
-43,386
-16,516
EBITDA
-
-17,726
-49,181
-35,756
-9,229